NeuroBionics: Tiny Bioelectric Fibers

This is a news story, published by TechCrunch, that relates primarily to Jurvetson news.

Jurvetson news

For more Jurvetson news, you can click here:

more Jurvetson news

medical innovations news

For more medical innovations news, you can click here:

more medical innovations news

TechCrunch news

For more news from TechCrunch, you can click here:

more news from TechCrunch

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about

today NeuroBionics

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest other medical device makers news, clinical device news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

NeuroBionics

TechCrunch

•

This MIT spinout wants to spool hair-thin fibers into patients' brains | TechCrunch

Summary

Nutrition label

66% Informative

NeuroBionics hopes to pipe bioelectric fibers the width of a human hair through blood vessels in the brain to deliver neuromodulation therapy.

The 18-month-old startup just raised $5 million in funding.

The fibers are powered by a fairly standard implantable battery that’s shaped like an Airpod case, designed to last five to 10 years .

Jurvetson wrote in an email, “But 99% of people who could benefit rightly refuse because it requires major open brain surgery with needles implanted into the deep brain regions.” As far as Jurvetson is concerned, tech like NeuroBionics ’ throws that market wide open — including because there is but a concentrated pocket of large and advanced hospitals that offer the surgery today . The “application domain” for the startup’s “minimally invasive stent,” enthuses Jurvetson , “is huge.”.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful